Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diagnostics drive Beckman and Biosite but not BD, while cardiovascular device firms are buoyant

This article was originally published in Clinica

Executive Summary

Rochester, New York-based eye care group Bausch & Lomb reported 11% growth in its cataract and vitreoretinal business in the fourth quarter, thanks to double-digit underlying growth in intraocular lens sales. Expansion in phacoemulsification product revenues more than offset a decline in viscoelastics, but refractive surgery revenues were hit by a drop in laser sales in North America.

Topics

UsernamePublicRestriction

Register

MT054164

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel